Amegadzie B Y, Holmes M H, Cole N B, Jones E V, Earl P L, Moss B
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Virology. 1991 Jan;180(1):88-98. doi: 10.1016/0042-6822(91)90012-z.
The gene, rpo 132, encoding the second-largest subunit of the vaccinia virus DNA-dependent RNA polymerase was identified and sequenced. Two complementary approaches, involving antiserum to purified vaccinia virus RNA polymerase, were used to locate the rpo 132 gene. One method involved the screening of a lambda gt11 library of vaccinia virus genome fragments and the other was based on the immunoprecipitation and polyacrylamide gel electrophoresis of the in vitro translation products of mRNA that hybridized to immobilized vaccinia virus DNA. The deduced open reading frame of the rpo 132 gene predicted a polypeptide of 1164 amino acid residues with sequence similarities to the second-largest RNA polymerase subunits of eubacteria, archaebacteria, and eukaryotes as well as to other poxviruses. Transcriptional analyses indicated that rpo 132 has both early and late RNA start sites and is expressed throughout infection.
编码痘苗病毒DNA依赖性RNA聚合酶第二大亚基的基因rpo 132被鉴定并测序。采用了两种互补方法,涉及针对纯化的痘苗病毒RNA聚合酶的抗血清,来定位rpo 132基因。一种方法是筛选痘苗病毒基因组片段的λgt11文库,另一种方法基于与固定化痘苗病毒DNA杂交的mRNA体外翻译产物的免疫沉淀和聚丙烯酰胺凝胶电泳。rpo 132基因推导的开放阅读框预测了一个由1164个氨基酸残基组成的多肽,其序列与真细菌、古细菌和真核生物的第二大亚基RNA聚合酶以及其他痘病毒相似。转录分析表明,rpo 132具有早期和晚期RNA起始位点,并且在整个感染过程中都有表达。